Track topics on Twitter Track topics that are important to you
Metrasens, a global leader in MRI Safety solutions for healthcare facilities announces today that it has commenced a patent infringement action in the Chinese courts against Nanjing Cloud Magnet Electronic Technology Limited.
MALVERN, England (PRWEB) January 18, 2019
Metrasens is a leading provider of advanced magnetic detection technologies. Founded in the UK, Metrasens has become a global industry leader in the provision of patient safety solutions to MRI facilities. Its Ferroguard® products have built a reputation as trustworthy ferromagnetic detection systems (FMDS) and are in use in 36 countries.
Metrasens terminated its distributor agreement in China with Nanjing Haole Technology Co., Ltd (“NH”) when it discovered that NH and its affiliate Nanjing Cloud Magnet Electronic Technology Limited (“Cloud Magnet”) produce and distribute products that directly compete with Ferroguard systems, in violation of the distribution agreement.
Metrasens pays great attentions to intellectual property protection. As early as 2013, it filed an application for a patent for invention with Chinese Patent Office. Patent No. 201380067644.6. entitled “False Alarm Reduction” was granted on December 11, 2018. Some of the designs and technical features of Cloud Magnet’s competing products, in its view, fall within the scope of its patent protection.
Metrasens values the Chinese market and its strong relationships with partners. It also has an abiding belief that the protection of its intellectual property is not only in respect of China’s legal system, but also its responsibility to Chinese customers. Consequently on December 19, 2018, Metrasens instigated a full patent infringement action against NH and Cloud Magnet in the IP Division of Nanjing Intermediate People’s Court based on the aforementioned patent, in respect of NH and Cloud Magnet’s ferromagnetic detection products: Cloud Magnet Scanner II, and Cloud Magnet Scanner II Plus (Case Reference: (2018) Su 01 Min Chu No. 3509). Metrasens values its intellectual property rights and will continue to take all necessary legal and commercial steps against NH and Cloud Magnet in China and elsewhere to prevent the manufacture and sale of products that are based on its proprietary technology and/or infringe its patents.
For the original version on PRWeb visit: https://www.prweb.com/releases/metrasens_instigates_a_patent_infringement_action_in_china_against_nanjing_cloud_magnet_electronic_technology_limited/prweb16044071.htmNEXT ARTICLE
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...